C8 Medisensors, a US-based company specialising in glucose monitoring, secured $24m in series C funding on Thursday from investors including General Electric’s GE Capital financial services division and its GE Healthcare division, which made the investment through its Healthymagination fund. C8 stated that GE joined existing investors in the round, but did not disclose the…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
